PREVALENCE OF GLUTAMATE CARBOXYPEPTIDASE II C1561T, REDUCED FOLATE CARRIER 1 A80G, AND METHIONINE SYNTHASE A2756G GENE POLYMORPHISMS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AMONG SOUTH INDIANS
Objective: Glutamate carboxypeptidase II (GCPII), reduced folate carrier 1 (RFC1), and methionine synthase (MTR) genes involved in the folate metabolic pathway may play a key role in the pathogenesis of diabetes and its complications. The present study aimed to investigate the prevalence of genetic polymorphisms of GCPII C1561T, RFC1 A80G, and MTR A2756G in individuals with type 2 diabetes mellitus (T2DM) among South Indians.
Methods: The study subjects consisted of 100 healthy individuals and 200 patients with T2DM. Genetic polymorphisms (GCPII C1561T, RFCI A80G, and MTR A2756G) in the folate metabolic pathway were analyzed by polymerase chain reaction-restriction fragment length polymorphism method. Statistical analysis was performed to test the level of significance.
Results: With regard to GCPII C1561T and MTR A2756G gene polymorphisms, significant differences were not found when diabetic patients (with and without complications) and controls were compared according to different statistical models (dominant, recessive, and overdominant) p>0.05. A case–control genetic association analysis of RFC1 A80G gene polymorphism has shown that there was 3.7-fold increased risk for patients without complications and 4.9-fold increased risk for diabetic patients with complications.
Conclusions: Our findings suggest that the GCPII C1561T and MTR A2756G gene polymorphisms were not significantly associated with diabetes and its complications. Whereas, the RFCI A80G gene polymorphism involved in folate metabolism confers increased risk for diabetes and its complications in South Indian population.
2. Weiner AS, Boyarskikh UA, Voronina EN, Selezneva IA, Sinkina TV, Lazarev AF, et al. Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. Cancer epidemiol 2012;36:e95-100.
3. Shane B. Folate chemistry and metabolism. In: Folate in Health and Disease. New York: Marcel Dekker;1995. p. 1-22.
4. Melse-Boonstra A, West CE, Katan MB, Kok FJ, Verhoef P. Bioavailability of heptaglutamyl relative to monoglutamyl folic acid in healthy adults. Am J Clin Nutr 2004;79:424-9.
5. Maraj BH, Leek JP, Karayi M, Ali M, Lench NJ, Markham AF. Detailed genetic mapping around a putative prostate-specific membrane antigen locus on human chromosome 11p11. 2. Cytogenet Cell Genet 1998;81:3-9.
6. O’Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, et al. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta 1998;1443:113-27.
7. Devlin AM, Ling EH, Peerson JM, Fernando S, Clarke R, Smith AD, et al. Glutamate carboxypeptidase II: A polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 2000;9:2837-44.
8. Matherly LH, Hou Z, Deng Y. Human reduced folate carrier: Translation of basic biology to cancer etiology and therapy. Cancer Metastasis Rev 2007;26:111-28.
9. Hou Z, Matherly LH. Biology of the major facilitative folate transporters SLC19A1 and SLC46A1. Curr Top Membr 2014; 73:175-204.
10. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, et al. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000;70:310-5.
11. Matherly LH, Hou Z. Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter. Vitam Horm 2008;79:145-84.
12. Frankenburg FR. The role of one-carbon metabolism in schizophrenia and depression. Harv Rev Psychiatry 2007;15:146-60.
13. Finkelstein JD. The metabolism of homocysteine: Pathways and regulation. Eur J Pediatr 1998;157:S40-4.
14. Szvetko AL, Fowdar J, Nelson J, Colson N, Tajouri L, Csurhes PA, et al. No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort. J Neurol Sci 2007;252:49-52.
15. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase cDNA cloning, gene localization, and expression. J Biol Chem 1997;272:3628-34.
16. Iranpur MV, Esmailizadeh AK, Horriat R, Asadi KE, Shiran B, Sorkheh K, et al. Rapid Extraction of High Quality DNA from Whole Blood Stored at 4ºC for Long Period. Iran: Department of Animal Science, Faculty of Agriculture, Shahrekord University, Shahrekord; 2002.
17. Neagos D, Cretu R, Tutulan-Cunita A, Stoian V, Bohiltea LC. RFC-1 gene polymorphism and the risk of down syndrome in Romanian population. Maedica (Buchar) 2010;5:280-5.
18. Zara-Lopes T, Gimenez-Martins AP, Nascimento-Filho CH, Castanhole-Nunes MM, Galbiatti-Dias AL, Padovani-Júnior JA, et al. Role of MTHFR C677T and MTR A2756G polymorphisms in thyroid and breast cancer development. Genet Mol Res 2016;15: 1-11.
19. Mir MM, Dar JA, Dar NA, Dar MS, Salam I, Lone MM, et al. Combined impact of polymorphism of folate metabolism genes; Glutamate carboxypeptidase, methylene tetrahydrofolate reductase and methionine synthase reductase on breast cancer susceptibility in Kashmiri women. Int J Health Sci 2008;2:3-14.
20. Vinukonda G, Mohammad NS, Jain JM, Chintakindi KP, Akella RR. Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians. Clin Chim Acta 2009;405:127-31.
21. Divyya S, Naushad SM, Addlagatta A, Murthy PV, Reddy CR, Digumarti RR, et al. Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility. Gene 2012;497:273-9.
22. Wittke-Thompson JK, Pluzhnikov A, Cox NJ. Rational inferences about departures from hardy-weinberg equilibrium. Am J Hum Genet 2005;76:967-86.
23. Naushad SM, Jamal MN, Prasad CK, Devi AR. Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians. Clin Chem Lab Med 2008;46:73-9.
24. Ashavaid TF, Shalia KK, Kondkar AA, Todur SP, Nair KG, Nair SR. Gene polymorphism and coronary risk factors in Indian population. Clin Chem Lab Med 2002;40:975-85.
25. Divyya S, Naushad SM, Kaul S, Anusha V, Subbarao SA, Kutala VK. Glutamate carboxypeptidase II (GCPII) genetic variants as determinants of hyperhomocysteinemia: Implications in stroke susceptibility. Indian J Biochem Biophys 2012;49:356-62.
26. Afman LA, Trijbels FJ, Blom HJ. The H475Y polymorphism in the glutamate carboxypeptidase II gene increases plasma folate without affecting the risk for neural tube defects in humans. J Nutr 2003;133:75-7.
27. Lievers KJ, Kluijtmans LA, Boers GH, Verhoef P, den Heijer M, Trijbels FJ, et al. Influence of a glutamate carboxypeptidase II (GCPII) polymorphism (1561C?T) on plasma homocysteine, folate and Vitamin B12 levels and its relationship to cardiovascular disease risk. Atherosclerosis 2002;164:269-73.
28. Götze T, Röcken C, Röhl FW, Wex T, Hoffmann J, Westphal S, et al. Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett 2007;251:228-36.
29. Fodinger M, Dierkes J, Skoupy S, Röhrer C, Hagen W, Puttinger H, et al. Effect of glutamate carboxypeptidase II and reduced folate carrier polymorhpisms on folate and total homocysteine concentrations in dialysis patients. J Am Soc Nephrol 2003;14:1314-9.
30. Halsted CH, Wong DH, Peerson JM, Warden CH, Refsum H, Smith AD, et al. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: The Hordaland homocysteine Study. Am J Clin Nutr 2007;86:514-21.
31. Saxena AK. Evaluation of genetic heterogeneity in glutamate carboxypeptidase II (H475Y) and reduced folate carrier (SLC19A1) gene variants increased risk factor for the development of neural tube defects in eastern region of India. Int J Genet Mol Biol 2012;4:10-5.
32. Lakshmi SV, Naushad SM, Rao DS, Kutala VK. Oxidative stress is associated with genetic polymorphisms in one-carbon metabolism in coronary artery disease. Cell Biochem Biophys 2013;67:353-61.
33. Sharif FA, Shubair ME, Zaharna MM, Ashour MJ. Altalalgah IO, et al. Genetic polymorphism and risk of having type 2 diabetes in a palestinian population: A study of 16 gene polymorphisms. Adv Diabetes Endocrinol 2018;3:6.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.